RenaissanceRe (RNR) PT Set at $152.00 by Citigroup

RenaissanceRe (NYSE:RNR) received a $152.00 price target from stock analysts at Citigroup in a report released on Friday. The firm currently has a “buy” rating on the insurance provider’s stock. Citigroup’s price target indicates a potential upside of 17.27% from the stock’s current price.

Several other brokerages also recently issued reports on RNR. UBS Group upped their price target on shares of RenaissanceRe from $135.00 to $144.00 and gave the stock a “neutral” rating in a report on Monday, November 6th. Zacks Investment Research upgraded shares of RenaissanceRe from a “sell” rating to a “hold” rating in a report on Friday, November 10th. Morgan Stanley lowered their price target on shares of RenaissanceRe from $144.00 to $142.00 and set an “equal weight” rating for the company in a report on Thursday, November 2nd. Wells Fargo & Co set a $140.00 price target on shares of RenaissanceRe and gave the stock a “hold” rating in a report on Tuesday, October 31st. Finally, Keefe, Bruyette & Woods reiterated a “hold” rating and set a $136.00 price target on shares of RenaissanceRe in a report on Monday, October 16th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $145.88.

RenaissanceRe (NYSE:RNR) opened at $129.61 on Friday. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.66 and a current ratio of 1.77. RenaissanceRe has a 1-year low of $116.50 and a 1-year high of $152.00.

RenaissanceRe (NYSE:RNR) last announced its quarterly earnings results on Wednesday, January 31st. The insurance provider reported $1.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.76 by $0.29. The company had revenue of $288.22 million during the quarter, compared to the consensus estimate of $227.65 million. RenaissanceRe had a negative net margin of 10.57% and a negative return on equity of 7.68%. The company’s revenue for the quarter was up 31.3% compared to the same quarter last year. During the same period in the prior year, the business earned $2.66 earnings per share. equities research analysts expect that RenaissanceRe will post 9.95 earnings per share for the current fiscal year.

RenaissanceRe announced that its board has authorized a share buyback plan on Friday, November 10th that authorizes the company to repurchase $500.00 million in shares. This repurchase authorization authorizes the insurance provider to repurchase shares of its stock through open market purchases. Stock repurchase plans are usually a sign that the company’s leadership believes its stock is undervalued.

In related news, SVP Sean G. Brosnan sold 1,391 shares of the stock in a transaction on Monday, November 27th. The stock was sold at an average price of $135.73, for a total value of $188,800.43. Following the completion of the sale, the senior vice president now directly owns 8,405 shares in the company, valued at $1,140,810.65. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Kevin Odonnell sold 5,000 shares of the stock in a transaction on Friday, December 1st. The shares were sold at an average price of $131.65, for a total value of $658,250.00. Following the completion of the sale, the chief executive officer now owns 190,707 shares of the company’s stock, valued at $25,106,576.55. The disclosure for this sale can be found here. Corporate insiders own 1.80% of the company’s stock.

A number of hedge funds and other institutional investors have recently bought and sold shares of RNR. PNC Financial Services Group Inc. increased its holdings in RenaissanceRe by 16.5% in the second quarter. PNC Financial Services Group Inc. now owns 2,352 shares of the insurance provider’s stock valued at $327,000 after purchasing an additional 333 shares during the period. Citigroup Inc. increased its holdings in RenaissanceRe by 262.5% in the second quarter. Citigroup Inc. now owns 1,566 shares of the insurance provider’s stock valued at $218,000 after purchasing an additional 1,134 shares during the period. Macquarie Group Ltd. increased its holdings in RenaissanceRe by 2,958.5% in the second quarter. Macquarie Group Ltd. now owns 37,130 shares of the insurance provider’s stock valued at $5,163,000 after purchasing an additional 35,916 shares during the period. The Manufacturers Life Insurance Company acquired a new stake in RenaissanceRe in the second quarter valued at $8,317,000. Finally, Americafirst Capital Management LLC acquired a new stake in RenaissanceRe in the second quarter valued at $161,000. Institutional investors and hedge funds own 90.46% of the company’s stock.

WARNING: “RenaissanceRe (RNR) PT Set at $152.00 by Citigroup” was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece on another site, it was illegally stolen and republished in violation of international trademark & copyright legislation. The original version of this piece can be viewed at https://www.dispatchtribunal.com/2018/02/11/renaissancere-rnr-pt-set-at-152-00-by-citigroup.html.

About RenaissanceRe

RenaissanceRe Holdings Ltd. provides reinsurance and insurance coverages and related services to a range of customers. The Company’s products include property, casualty and specialty reinsurance and certain insurance products principally distributed through intermediaries. Its segments include Property; Casualty and Specialty, and Other category.

Analyst Recommendations for RenaissanceRe (NYSE:RNR)

Receive News & Ratings for RenaissanceRe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RenaissanceRe and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply